United Therapeutics Corpo...

NASDAQ: UTHR · Real-Time Price · USD
312.86
0.80 (0.26%)
At close: Aug 15, 2025, 3:59 PM
313.13
0.09%
After-hours: Aug 15, 2025, 05:27 PM EDT

United Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.7B 1.21B 961.2M 894.8M
Short-Term Investments
1.57B 1.79B 1.88B 1.04B
Long-Term Investments
1.48B 1.91B 1.32B 1.65B
Other Long-Term Assets
222.1M 151.8M 114.3M 108.2M
Receivables
279.3M 278.9M 220.4M 198.7M
Inventory
157.9M 111.8M 102M 93.8M
Other Current Assets
169.7M 166.2M 219.2M 100.4M
Total Current Assets
3.87B 3.55B 3.38B 2.32B
Property-Plant & Equipment
1.22B 1.05B 861.5M 780.9M
Goodwill & Intangibles
111.9M 114.2M 44.5M 44.6M
Total Long-Term Assets
3.49B 3.62B 2.66B 2.85B
Total Assets
7.36B 7.17B 6.04B 5.17B
Account Payables
6M 5.6M 4.1M 3.8M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
300M 400M n/a n/a
Other Current Liabilities
432.1M 40.5M 13M 248M
Total Current Liabilities
738.1M 804.4M 343.2M 305.4M
Long-Term Debt
n/a 300M 800M 800M
Other Long-Term Liabilities
181.9M 77.8M 104.6M 104.8M
Total Long-Term Liabilities
181.9M 377.8M 904.6M 904.8M
Total Liabilities
920M 1.18B 1.25B 1.21B
Total Debt
300M 700M 800M 800M
Common Stock
800K 700K 700K 700K
Retained Earnings
7.22B 6.03B 5.04B 4.32B
Comprehensive Income
-3.4M -12.8M -55.5M -23M
Shareholders Equity
6.44B 5.98B 4.8B 3.96B
Total Investments
3.05B 3.7B 3.19B 2.69B